Virulence of the H1N1 2009 Pandemic Influenza Virus
Keywords:
No KeywordAbstract
No Abstract
References
1. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez
M, Qui?ones-Falconi F, Bautista E, et al. Pneumonia and respiratory
failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med.
2009 Aug 13;361(7):680-9.
2. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD,
Hollingsworth TD, et al. Pandemic potential of a strain of influenza A
(H1N1): early findings. Science. 2009 Jun 19;324(5934):1557-61.
3. Hadler JL, Konty K, McVeigh KH, Fine A, Eisenhower D, Kerker B,
et al. Case fatality rates based on population estimates of influenza-like
illness due to novel H1N1 influenza: New York City, May-June 2009.
PLoS One. 2010 Jul 21;5(7):e11677.
4. Wielders CC, van Lier EA, van 't Klooster TM, van Gageldonk-Lafeber
AB, van den Wijngaard CC, Haagsma JA, et al., The burden of 2009
pandemic influenza A(H1N1) in the Netherlands. Eur J Public Health.
2010 Dec 22.
5. Herberg JA, Jones KD, Paulus S, Gormley S, Muir D, Cooper M et al.
Comparison of Pandemic and Seasonal Influenza Reveals Higher Mortality
and Increased Prevalence of Shock in Children with Severe H1n1/09
Infection. Pediatr Infect Dis J. 2011 Nov 22.
6. Riquelme R, Torres A, Rioseco ML, Ewig S, Cill?niz C, Riquelme M,
et al. Influenza pneumonia: a comparison between seasonal influenza
virus and H1N1 pandemic. Eur Respir J. Eur Respir J. 2011 Jan 27.
7. Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar
J, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis
of 100 fatal cases in the United States. Am J Pathol. 2010 Jul;177(1):166-75.
8. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K,
Peiris M, et al. Influenza A H5N1 replication sites in humans. Emerg
Infect Dis. 2005 Jul;11(7):1036-41.
9. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. In
vitro and in vivo characterization of new swine-origin H1N1 influenza
viruses. Nature. 2009 Aug 20;460(7258):1021-5.
10. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H,
et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1)
influenza viruses in ferrets and mice. Science. 2009 Jul 24;325(5939):484-7.
11. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ,
Bestebroer TM, et al. Pathogenesis and transmission of swine-origin 2009
A(H1N1) influenza virus in ferrets. Science. 2009 Jul 24;325(5939):481-3.
12. Stieneke-Gr?ber A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C,
et al. Influenza virus hemagglutinin with multibasic cleavage site is activated
by furin, a subtilisin-like endoprotease. EMBO J. 1992 Jul;11(7):2407-14.
13. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu:
influenza virus receptors in the human airway. Nature. 2006 Mar 23;440
(7083):435-6.
14. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, et al.
Induction of proinflammatory cytokines in human macrophages by influenza
A (H5N1) viruses: a mechanism for the unusual severity of human
disease? Lancet. 2002 Dec 7;360(9348):1831-7.
15. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN,
et al. Fatal outcome of human influenza A (H5N1) is associated with
high viral load and hypercytokinemia. Nat Med. 2006 Oct;12(10):1203-7.
16. Guan Y, Poon LL, Cheung CY, Ellis TM, Lim W, Lipatov AS, et al.
H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A.
2004 May 25;101(21):8156-61.
17. Tumpey TM, Garc?a-Sastre A, Taubenberger JK, Palese P, Swayne DE,
Pantin-Jackwood MJ, et al. Pathogenicity of influenza viruses with genes
from the 1918 pandemic virus: functional roles of alveolar macrophages
and neutrophils in limiting virus replication and mortality in mice. J Virol.
2005 Dec;79(23):14933-44.
18. Monteerarat Y, Sakabe S, Ngamurulert S, Srichatraphimuk S, Jiamtom
W, Chaichuen K, et al. Induction of TNF-alpha in human macrophages
by avian and human influenza viruses. Arch Virol. 2010 Aug;155(8):1273-9.
19. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, et al. A
novel influenza A virus mitochondrial protein that induces cell death.
Nat Med. 2001 Dec;7(12):1306-12.
20. Seo SH, Hoffmann E, Webster RG. The NS1 gene of H5N1 influenza
viruses circumvents the host anti-viral cytokine responses. Virus Res. 2004
Jul;103(1-2):107-13.
21. Zamarin D, Garc?a-Sastre A, Xiao X, Wang R, Palese P. Influenza virus
PB1-F2 protein induces cell death through mitochondrial ANT3 and
VDAC1. PLoS Pathog. 2005 Sep;1(1):e4.
22. Li Z, Jiang Y, Jiao P, Wang A, Zhao F, Tian G, et al. The NS1 gene
contributes to the virulence of H5N1 avian influenza viruses. J Virol.
2006 Nov;80(22):11115-23.
23. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA. A new influenza
virus virulence determinant: the NS1 protein four C-terminal residues
modulate pathogenicity. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):
4381-6.
24. Zielecki F, Semmler I, Kalthoff D, Voss D, Mauel S, Gruber AD, et al.
Virulence determinants of avian H5N1 influenza A virus in mammalian
and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein.
J Virol. 2010 Oct;84(20):10708-18.
25. Kang YM, Song BM, Lee JS, Kim HS, Seo SH. Pandemic H1N1 influenza
virus causes a stronger inflammatory response than seasonal H1N1 influenza
virus in ferrets. Arch Virol. 2011 Jan 15.
26. Sakabe S, Iwatsuki-Horimoto K, Takano R, Nidom CA, Le MT, Nagamura-
Inoue T, et al. Cytokine production by primary human macrophages
infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza
viruses. J Gen Virol. 2011 Mar 2.
27. Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, Chai W, et al.
Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus
determined by carbohydrate microarray. Nat Biotechnol. 2009 Sep;27(9):
797-9.
28. Chutinimitkul S, Herfst S, Steel J, Lowen AC, Ye J, van Riel D, et al.
Virulence-associated substitution D222G in the hemagglutinin of 2009
pandemic influenza A(H1N1) virus affects receptor binding. J Virol. 2010
Nov;84(22):11802-13.
29. Zheng B, Chan KH, Zhang AJ, Zhou J, Chan CC, Poon VK, et al. D225G
mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus
enhances virulence in mice. Exp Biol Med (Maywood). 2010 Aug;235(8):981-8.
30. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki
H, et al. Adaptation of pandemic H1N1 influenza viruses in mice. J Virol.
2010 Sep;84(17):8607-16.
31. Ammon CE. Spanish flu epidemic in 1918 in Geneva, Switzerland. Euro
Surveill. 2002 Dec;7(12):190-2.
32. Cheng KF, Leung PC. What happened in China during the 1918 influenza pandemic? Int J Infect Dis. 2007 Jul;11(4):360-4.
33. Shu LP, Sharp GB, Lin YP, Claas EC, 33. Shu LP, Sharp GB, Lin YP, Claas EC, Krauss SL, Shortridge KF, et al.
Genetic reassortment in pandemic and interpandemic influenza viruses. A study of 122 viruses infecting humans. Eur J Epidemiol. 1996 Feb;12(1):63-70.
34. Webster RG, Sharp GB, Claas EC. Interspecies transmission of influenza viruses. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 2):S25-30.
35. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, et al. Pandemic Swine-Origin H1N1 Influenza A Isolates Show Heterogeneous
Virulence in Macaques. J Virol. 2011 Feb;85(3):1214-23.
36. Xu L, Bao L, Lv Q, Deng W, Ma Y, Li F, et al. A single-amino-acid substitution in the HA protein changes the replication and pathogenicity
of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J. 2010 Nov 18;7:325.
37. Job ER, Deng YM, Tate MD, Bottazzi B, Crouch EC, Dean MM, et al.
Pandemic H1N1 influenza A viruses are resistant to the antiviral activities
of innate immune proteins of the collectin and pentraxin superfamilies.
J Immunol. 2010 Oct 1;185(7):4284-91.
38. Qi L, Kash JC, Dugan VG, Jagger BW, Lau YF, Sheng ZM, et al. The
ability of pandemic influenza virus hemagglutinins to induce lower respiratory
pathology is associated with decreased surfactant protein D binding.
Virology. 2011 Apr 10;412(2):426-34.
39. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, McCullers JA.
N-linked glycosylation attenuates H3N2 influenza viruses. J Virol. 2007
Aug;81(16):8593-600.
40. Hartshorn KL, Webby R, White MR, Tecle T, Pan C, Boucher S, et al.
Role of viral hemagglutinin glycosylation in anti-influenza activities of
recombinant surfactant protein D. Respir Res. 2008 Sep 23;9:65.
41. Kiseleva I, Larionova N, Kuznetsov V, Rudenko L. Phenotypic characteristics
of novel swine-origin influenza A/California/07/2009 (H1N1)
virus. Influenza Other Respi Viruses. 2010 Jan;4(1):1-5.
42. Konno J. Studies on several inhibitors against influenza viruses. 2. beta-
Inhibitor, its biological and physicochemical properties with particular
emphasis on the differences from alpha-inhibitor, immune serum and
properdin. Tohoku J Exp Med. 1958 Apr 25;67(4):391-405.
43. Ryan-Poirier KA, Kawaoka Y. Distinct glycoprotein inhibitors of influenza
A virus in different animal sera. J Virol. 1991 Jan;65(1):389-95.
44. Ryan-Poirier KA Kawaoka Y. Alpha 2-macroglobulin is the major neutralizing
inhibitor of influenza A virus in pig serum. Virology. 1993 Apr;193
(2):974-6.
45. Kongchanagul A, Suptawiwat O, Boonarkart C, et al. Decreased expression
of surfactant protein D mRNA in human lungs from fatal H5N1
avian influenza cases. J Med Virol: in press.
46. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul
A, Ungchusak K, et al. Apoptosis and pathogenesis of avian influenza
A (H5N1) virus in humans. Emerg Infect Dis. 2007 May;13(5):708-12.
47. Busani S, Girardis M, Biagioni E, Pasetto A, Sambri V. Surfactant therapy
and intravenous zanamivir in severe respiratory failure due to persistent
influenza A/H1N1 2009 virus infection. Am J Respir Crit Care Med.
2010 Nov 15;182(10):1334.Krauss SL,
M, Qui?ones-Falconi F, Bautista E, et al. Pneumonia and respiratory
failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med.
2009 Aug 13;361(7):680-9.
2. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD,
Hollingsworth TD, et al. Pandemic potential of a strain of influenza A
(H1N1): early findings. Science. 2009 Jun 19;324(5934):1557-61.
3. Hadler JL, Konty K, McVeigh KH, Fine A, Eisenhower D, Kerker B,
et al. Case fatality rates based on population estimates of influenza-like
illness due to novel H1N1 influenza: New York City, May-June 2009.
PLoS One. 2010 Jul 21;5(7):e11677.
4. Wielders CC, van Lier EA, van 't Klooster TM, van Gageldonk-Lafeber
AB, van den Wijngaard CC, Haagsma JA, et al., The burden of 2009
pandemic influenza A(H1N1) in the Netherlands. Eur J Public Health.
2010 Dec 22.
5. Herberg JA, Jones KD, Paulus S, Gormley S, Muir D, Cooper M et al.
Comparison of Pandemic and Seasonal Influenza Reveals Higher Mortality
and Increased Prevalence of Shock in Children with Severe H1n1/09
Infection. Pediatr Infect Dis J. 2011 Nov 22.
6. Riquelme R, Torres A, Rioseco ML, Ewig S, Cill?niz C, Riquelme M,
et al. Influenza pneumonia: a comparison between seasonal influenza
virus and H1N1 pandemic. Eur Respir J. Eur Respir J. 2011 Jan 27.
7. Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar
J, et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis
of 100 fatal cases in the United States. Am J Pathol. 2010 Jul;177(1):166-75.
8. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K,
Peiris M, et al. Influenza A H5N1 replication sites in humans. Emerg
Infect Dis. 2005 Jul;11(7):1036-41.
9. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. In
vitro and in vivo characterization of new swine-origin H1N1 influenza
viruses. Nature. 2009 Aug 20;460(7258):1021-5.
10. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H,
et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1)
influenza viruses in ferrets and mice. Science. 2009 Jul 24;325(5939):484-7.
11. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ,
Bestebroer TM, et al. Pathogenesis and transmission of swine-origin 2009
A(H1N1) influenza virus in ferrets. Science. 2009 Jul 24;325(5939):481-3.
12. Stieneke-Gr?ber A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C,
et al. Influenza virus hemagglutinin with multibasic cleavage site is activated
by furin, a subtilisin-like endoprotease. EMBO J. 1992 Jul;11(7):2407-14.
13. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu:
influenza virus receptors in the human airway. Nature. 2006 Mar 23;440
(7083):435-6.
14. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, et al.
Induction of proinflammatory cytokines in human macrophages by influenza
A (H5N1) viruses: a mechanism for the unusual severity of human
disease? Lancet. 2002 Dec 7;360(9348):1831-7.
15. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN,
et al. Fatal outcome of human influenza A (H5N1) is associated with
high viral load and hypercytokinemia. Nat Med. 2006 Oct;12(10):1203-7.
16. Guan Y, Poon LL, Cheung CY, Ellis TM, Lim W, Lipatov AS, et al.
H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A.
2004 May 25;101(21):8156-61.
17. Tumpey TM, Garc?a-Sastre A, Taubenberger JK, Palese P, Swayne DE,
Pantin-Jackwood MJ, et al. Pathogenicity of influenza viruses with genes
from the 1918 pandemic virus: functional roles of alveolar macrophages
and neutrophils in limiting virus replication and mortality in mice. J Virol.
2005 Dec;79(23):14933-44.
18. Monteerarat Y, Sakabe S, Ngamurulert S, Srichatraphimuk S, Jiamtom
W, Chaichuen K, et al. Induction of TNF-alpha in human macrophages
by avian and human influenza viruses. Arch Virol. 2010 Aug;155(8):1273-9.
19. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, et al. A
novel influenza A virus mitochondrial protein that induces cell death.
Nat Med. 2001 Dec;7(12):1306-12.
20. Seo SH, Hoffmann E, Webster RG. The NS1 gene of H5N1 influenza
viruses circumvents the host anti-viral cytokine responses. Virus Res. 2004
Jul;103(1-2):107-13.
21. Zamarin D, Garc?a-Sastre A, Xiao X, Wang R, Palese P. Influenza virus
PB1-F2 protein induces cell death through mitochondrial ANT3 and
VDAC1. PLoS Pathog. 2005 Sep;1(1):e4.
22. Li Z, Jiang Y, Jiao P, Wang A, Zhao F, Tian G, et al. The NS1 gene
contributes to the virulence of H5N1 avian influenza viruses. J Virol.
2006 Nov;80(22):11115-23.
23. Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA. A new influenza
virus virulence determinant: the NS1 protein four C-terminal residues
modulate pathogenicity. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):
4381-6.
24. Zielecki F, Semmler I, Kalthoff D, Voss D, Mauel S, Gruber AD, et al.
Virulence determinants of avian H5N1 influenza A virus in mammalian
and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein.
J Virol. 2010 Oct;84(20):10708-18.
25. Kang YM, Song BM, Lee JS, Kim HS, Seo SH. Pandemic H1N1 influenza
virus causes a stronger inflammatory response than seasonal H1N1 influenza
virus in ferrets. Arch Virol. 2011 Jan 15.
26. Sakabe S, Iwatsuki-Horimoto K, Takano R, Nidom CA, Le MT, Nagamura-
Inoue T, et al. Cytokine production by primary human macrophages
infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza
viruses. J Gen Virol. 2011 Mar 2.
27. Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, Chai W, et al.
Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus
determined by carbohydrate microarray. Nat Biotechnol. 2009 Sep;27(9):
797-9.
28. Chutinimitkul S, Herfst S, Steel J, Lowen AC, Ye J, van Riel D, et al.
Virulence-associated substitution D222G in the hemagglutinin of 2009
pandemic influenza A(H1N1) virus affects receptor binding. J Virol. 2010
Nov;84(22):11802-13.
29. Zheng B, Chan KH, Zhang AJ, Zhou J, Chan CC, Poon VK, et al. D225G
mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus
enhances virulence in mice. Exp Biol Med (Maywood). 2010 Aug;235(8):981-8.
30. Ilyushina NA, Khalenkov AM, Seiler JP, Forrest HL, Bovin NV, Marjuki
H, et al. Adaptation of pandemic H1N1 influenza viruses in mice. J Virol.
2010 Sep;84(17):8607-16.
31. Ammon CE. Spanish flu epidemic in 1918 in Geneva, Switzerland. Euro
Surveill. 2002 Dec;7(12):190-2.
32. Cheng KF, Leung PC. What happened in China during the 1918 influenza pandemic? Int J Infect Dis. 2007 Jul;11(4):360-4.
33. Shu LP, Sharp GB, Lin YP, Claas EC, 33. Shu LP, Sharp GB, Lin YP, Claas EC, Krauss SL, Shortridge KF, et al.
Genetic reassortment in pandemic and interpandemic influenza viruses. A study of 122 viruses infecting humans. Eur J Epidemiol. 1996 Feb;12(1):63-70.
34. Webster RG, Sharp GB, Claas EC. Interspecies transmission of influenza viruses. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 2):S25-30.
35. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, et al. Pandemic Swine-Origin H1N1 Influenza A Isolates Show Heterogeneous
Virulence in Macaques. J Virol. 2011 Feb;85(3):1214-23.
36. Xu L, Bao L, Lv Q, Deng W, Ma Y, Li F, et al. A single-amino-acid substitution in the HA protein changes the replication and pathogenicity
of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J. 2010 Nov 18;7:325.
37. Job ER, Deng YM, Tate MD, Bottazzi B, Crouch EC, Dean MM, et al.
Pandemic H1N1 influenza A viruses are resistant to the antiviral activities
of innate immune proteins of the collectin and pentraxin superfamilies.
J Immunol. 2010 Oct 1;185(7):4284-91.
38. Qi L, Kash JC, Dugan VG, Jagger BW, Lau YF, Sheng ZM, et al. The
ability of pandemic influenza virus hemagglutinins to induce lower respiratory
pathology is associated with decreased surfactant protein D binding.
Virology. 2011 Apr 10;412(2):426-34.
39. Vigerust DJ, Ulett KB, Boyd KL, Madsen J, Hawgood S, McCullers JA.
N-linked glycosylation attenuates H3N2 influenza viruses. J Virol. 2007
Aug;81(16):8593-600.
40. Hartshorn KL, Webby R, White MR, Tecle T, Pan C, Boucher S, et al.
Role of viral hemagglutinin glycosylation in anti-influenza activities of
recombinant surfactant protein D. Respir Res. 2008 Sep 23;9:65.
41. Kiseleva I, Larionova N, Kuznetsov V, Rudenko L. Phenotypic characteristics
of novel swine-origin influenza A/California/07/2009 (H1N1)
virus. Influenza Other Respi Viruses. 2010 Jan;4(1):1-5.
42. Konno J. Studies on several inhibitors against influenza viruses. 2. beta-
Inhibitor, its biological and physicochemical properties with particular
emphasis on the differences from alpha-inhibitor, immune serum and
properdin. Tohoku J Exp Med. 1958 Apr 25;67(4):391-405.
43. Ryan-Poirier KA, Kawaoka Y. Distinct glycoprotein inhibitors of influenza
A virus in different animal sera. J Virol. 1991 Jan;65(1):389-95.
44. Ryan-Poirier KA Kawaoka Y. Alpha 2-macroglobulin is the major neutralizing
inhibitor of influenza A virus in pig serum. Virology. 1993 Apr;193
(2):974-6.
45. Kongchanagul A, Suptawiwat O, Boonarkart C, et al. Decreased expression
of surfactant protein D mRNA in human lungs from fatal H5N1
avian influenza cases. J Med Virol: in press.
46. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul
A, Ungchusak K, et al. Apoptosis and pathogenesis of avian influenza
A (H5N1) virus in humans. Emerg Infect Dis. 2007 May;13(5):708-12.
47. Busani S, Girardis M, Biagioni E, Pasetto A, Sambri V. Surfactant therapy
and intravenous zanamivir in severe respiratory failure due to persistent
influenza A/H1N1 2009 virus infection. Am J Respir Crit Care Med.
2010 Nov 15;182(10):1334.Krauss SL,
Downloads
Published
03-04-2020
How to Cite
Auewarakul, P. . (2020). Virulence of the H1N1 2009 Pandemic Influenza Virus. Siriraj Medical Journal, 63(2), 60–63. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/240909
Issue
Section
Special Issue
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
